Is GPT Healthcare the Best Stock in Its Sector? A Look at the Numbers
- September 25, 2026
- Posted by: Kunal Singla
- Category: Market
GPT Healthcare CMP Rs 161 (25 Sep 2026). Market cap Rs 1,321 Cr. ROE 15.67%. P/E 27.95x versus Industry P/E 94.52x.
Quick Answer
GPT Healthcare is one of the names investors compare when screening the Healthcare sector, built on a 15.67% return on equity and a P/E of 27.95x against an Industry P/E of 94.52x. Whether GPT Healthcare is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is GPT Healthcare the best stock in its sector? The stock trades on the NSE at Rs 161 as of 25 September 2026, within its 52-week range of Rs 115.00 to Rs 175.00. GPT Healthcare Ltd operates multi-specialty hospitals in Eastern India.
GPT Healthcare sits in the Healthcare sector, and its 15.67% ROE and 27.95x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About GPT Healthcare
GPT Healthcare Ltd operates multi-specialty hospitals in Eastern India. It operates multi-specialty hospitals in Eastern India, and the stock is trading near its 52-week high. At a market capitalisation of Rs 1,321 Cr, it is tracked as part of the Healthcare sector on Univest.
Is GPT Healthcare the Best Stock in Its Sector?
GPT Healthcare makes its case as the best stock in its sector primarily on return on equity and balance sheet strength, combining a 15.67% ROE with a 27.95x P/E against the sector’s 94.52x Industry P/E. GPT Healthcare’s 27.95x P/E is far below the 94.52x Industry P/E, a benchmark skewed by larger hospital chains, with a 15.67% ROE that is a healthy figure among the Healthcare peers covered in this series.
| Metric | GPT Healthcare |
|---|---|
| CMP (NSE) | Rs 161.42 |
| 52-Week High / Low | Rs 175.00 / Rs 115.00 |
| Market Cap | Rs 1,321 Cr |
| P/E (TTM) vs Industry P/E | 27.95x vs 94.52x |
| P/B | 4.90 |
| ROE | 15.67% |
| EPS (TTM) | Rs 5.76 |
| Dividend Yield | 1.55% |
| Debt to Equity | 0.34 |
Compare GPT Healthcare Against Other Healthcare Sector Stocks
How GPT Healthcare Compares Against Its Healthcare Sector Peers
The table below sets GPT Healthcare against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| GPT Healthcare | 1,321 | 27.95 | 15.67% | 0.34 |
| Dr. Agarwal’s Health Care | 15,908 | 85.92 | 6.58% | 0.53 |
| Gaudium IVF and Women Health | 844 | 36.48 | 16.06% | 0.16 |
| Peer average (2 companies) | – | 61.20 | 11.32% | 0.35 |
Against this peer set, GPT Healthcare’s 15.67% ROE is above the 11.32% peer average, and its P/E of 27.95x runs below the peer average of 61.20x. GPT Healthcare’s 27.95x P/E is far below the 94.52x Industry P/E, a benchmark skewed by larger hospital chains, with a 15.67% ROE that is a healthy figure among the Healthcare peers covered in this series.
What Makes GPT Healthcare Worth Watching in Healthcare
- Well below Industry P/E: A 27.95x P/E against a 94.52x Industry P/E is a wide discount, though the benchmark here is skewed by richer, larger hospital chains.
- Strong ROE: A 15.67% ROE is a healthy figure for a regional multi-specialty hospital operator.
- Eastern India hospital network: Operating multi-specialty hospitals concentrated in Eastern India gives GPT Healthcare a regionally focused healthcare delivery franchise.
GPT Healthcare Valuation: Is It Justified?
GPT Healthcare’s 27.95x P/E is far below the 94.52x Industry P/E, a benchmark skewed by larger hospital chains, with a 15.67% ROE that is a healthy figure among the Healthcare peers covered in this series. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is GM Breweries the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track GPT Healthcare and other Healthcare sector stocks.
How to Track GPT Healthcare Before You Invest
Before deciding whether GPT Healthcare deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for GPT Healthcare to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
GPT Healthcare earns a place in the best stock in its sector conversation on the strength of a 15.67% ROE and a P/E of 27.95x against a 94.52x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is GPT Healthcare the best stock in its sector?
Ans. GPT Healthcare has a 15.67% ROE and trades at 27.95x P/E against a 94.52x Industry P/E, and compares above the peer average ROE of 11.32% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of GPT Healthcare?
Ans. GPT Healthcare was trading at Rs 161.42 on the NSE as of 25 September 2026, within its 52-week range of Rs 115.00 to Rs 175.00.
What sector does GPT Healthcare belong to?
Ans. GPT Healthcare is classified under the Healthcare sector on Univest.
How does GPT Healthcare compare to its sector peers on P/E?
Ans. GPT Healthcare’s P/E of 27.95x is below the 61.20x average of the 2 named peers compared in this article.
What is GPT Healthcare’s return on equity?
Ans. GPT Healthcare reported a return on equity of 15.67%, which is above the 11.32% average of its named peers in this comparison.
Should I invest in GPT Healthcare based on its sector position?
Ans. GPT Healthcare’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
